HEMC.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
HEMC.STHemcheck Sweden AB (publ)	$0.23	+26.11%	$9M	—
BONZUN.STBonzun AB (publ)	$0.01	+0.00%	$7M	—
CLINE-B.STCline Scientific AB (publ)	$0.07	+0.00%	$3M	—
CYXO.STCyxone AB (publ)	$0.02	+0.00%	$7M	—
DEAR.STDuearity AB (publ)	$0.02	+0.00%	$3M	—
IDOGEN.STIdogen AB (publ)	$0.12	-2.82%	$13M	—
L2S.STLearning 2 Sleep L2S AB (publ)	$0.02	+2.50%	$12M	—

Source: Financial Modeling Prep · peers by sector/industry

Hemcheck Sweden AB (publ)

Hemcheck Sweden AB (publ) is a Swedish medical technology company. They specialize in developing and marketing Helge, a device capable of identifying hemolysis in blood samples at the point of care. The company's services are primarily aimed at emergency departments within the European Union and the United States. Hemcheck was founded in 2010 and is based in Karlstad, Sweden.

www.hemcheck.com

Employees: 1
IPO / List date: Mar 15, 2017
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds HEMC.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in HEMC.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded HEMC.ST yet.